一名药剂师融入澳大利亚的全科医院:药品优化护理的不断发展模式
Margaret Jordan1, Judy Mullan2, Adele Stewart3
1Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia.
The International journal of pharmacy practice
|October 12, 2023
概括
澳大利亚的一项试点通用实践药剂师 (GPP) 模型通过优化药物和减缓处方,特别是阿片类药物,成功地减少了药物危害. 这种方法提高了患者的安全性,并解决了药物管理中的关键障碍.
科学领域:
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
- 一般实践 药房 药房
背景情况:
- 在澳大利亚,一般实践药剂师 (GPP) 的作用正在扩大.
- 开发了一种试点GPP护理模式,以优化药物治疗对那些有药物相关危害风险的患者的药物治疗.
研究的目的:
- 评估GPP护理模式,以优化药物治疗,重点关注危险患者的抑郁症.
- 探索参与者对GPP护理模式的看法.
主要方法:
- 一个单一实践研究有两个阶段:关于药物调和,优化和降低处方的定量数据收集 (第一阶段),以及对参与者的观点进行定性访谈 (第二阶段).
- 包括药物审查,药物计划的制定和阿片类药物剂量变化的分析.
- 对与全科医生,患者和护理人员的采访进行主题分析.
主要成果:
- 198名多种疾病患者接受了GPP咨询.
- 在88%的咨询中解决了药物差异;在54%的咨询中出现了降低处方,GPP推接受率为86%.
- 6个月和9个月后,阿片类药物的剂量显著减少 (P < .0001).
结论:
- 通用诊所为药物优化和减缓处方提供了重要的机会.
- 证明的GPP护理模式有效地实现了药物降低处方,减少了风险人群的潜在危害.
- 该模型解决了已识别的障碍,并支持药物管理中的共享决策.
相关概念视频
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Pharmacokinetics: Overview
6.4K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
6.4K
Factors Influencing Drug Absorption: Presystemic Elimination
242
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
242
Pharmacovigilance
863
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
863
Analysis of Population Pharmacokinetic Data
268
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
268
Drug Administration and Therapy Phases: Overview
489
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
489


